For help on how to get the results you want, see our search tips.
4 results
Medicine
European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter
Maximum residue limits Remove Maximum residue limits filter
Summaries of opinion Remove Summaries of opinion filter
Medicine type
Generic Remove Generic filter
Biosimilar Remove Biosimilar filter
Accelerated assessment Remove Accelerated assessment filter
Patient safety
Yes Remove Yes filter
-
List item
Human medicine European public assessment report (EPAR): Capecitabine Medac (updated)
capecitabine, Colorectal Neoplasms
Date of authorisation: 19/11/2012,
, Revision: 12, Authorised, Last updated: 25/04/2022
-
List item
Human medicine European public assessment report (EPAR): Capecitabine Accord
capecitabine, Colonic Neoplasms; Breast Neoplasms; Colorectal Neoplasms; Stomach Neoplasms
Date of authorisation: 20/04/2012,, Revision: 16, Authorised, Last updated: 10/12/2021
-
List item
Human medicine European public assessment report (EPAR): Capecitabine Teva
capecitabine, Colonic Neoplasms; Breast Neoplasms; Colorectal Neoplasms; Stomach Neoplasms
Date of authorisation: 20/04/2012,, Revision: 15, Authorised, Last updated: 08/09/2021
-
List item
Human medicine European public assessment report (EPAR): Ecansya (previously Capecitabine Krka)
capecitabine, Colonic Neoplasms; Breast Neoplasms; Colorectal Neoplasms; Stomach Neoplasms
Date of authorisation: 20/04/2012,, Revision: 13, Authorised, Last updated: 23/04/2021